A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Duncan McKechnie.

Business address: C/O Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA, 02210
Top holdings (ownership): VRTX

Get insider transactions for this reporting owner

Duncan McKechnie has filed 5 SEC EDGAR filings since 02 Jul 2025

Recent SEC filings for Duncan McKechnie including 4, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	FORM 4	19 Feb 2026	17 Feb 2026	000-19319
4	Open 4 document	View SEC filing for 4	FORM 4	18 Feb 2026	13 Feb 2026	000-19319
4	Open 4 document	View SEC filing for 4	FORM 4	12 Feb 2026	10 Feb 2026	000-19319
4	Open 4 document	View SEC filing for 4	FORM 4	26 Jan 2026	22 Jan 2026	000-19319
3	Open 3 document	View SEC filing for 3	FORM 3	02 Jul 2025	01 Jul 2025	000-19319

Duncan McKechnie files with the SEC under CIK 0002062139. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.